Eterna Therapeutics Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
ERNA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1035 Cambridge Street, Suite 18 A, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 12/22/2023

Eterna Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Charles Cherington 10%+ Owner $8.31M Sep 23, 2024
Freebird Partners LP 10%+ Owner $1.5M Dec 14, 2023
George P. Denny III 10%+ Owner $1.13M Dec 2, 2022
John D. Halpern 10%+ Owner $1.12M Dec 2, 2022
Nicholas J. Singer Director $962K Dec 2, 2022
Roger Sidhu Chief Medical Officer $200K Sep 20, 2022
Kevin DAmour Chief Scientific Officer $159K Jun 28, 2022
Sandra Gurrola Sr. VP of Finance $3.38K Jun 21, 2024
Jay Sial Chief Administration Officer Mar 11, 2022
Erin S. Enright Director Jan 14, 2022
Luba Greenwood Director Dec 8, 2021
Andrew Jackson Chief Financial Officer Jun 3, 2022
Erich Mohr Director Dec 8, 2021
Howard J. Federoff CEO & President, Director Mar 11, 2022
Heather B. Redman Director Jan 14, 2022
William A. Wexler Director Aug 1, 2022
Gregory Fiore Director Aug 1, 2022
Dennis Langer Director Dec 8, 2021
Binder Brant Former director Aug 8, 2023
Dorothy Clarke General Counsel, Director Jan 1, 2024
Peter Cicala Director Apr 26, 2024
James Arthur Bristol Director Apr 26, 2024
Sanjeev Luther President and CEO, Director Jan 1, 2024
Richard W. Wagner Former director Aug 8, 2023
Matthew Angel President and CEO, Director Jan 12, 2023

Recent Insider Transactions by Companies or Individuals for Eterna Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.